Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study
Purpose Neurogenic lower urinary tract dysfunction (NLUTD) is highly prevalent among patients with neurologic disorders. Some studies have demonstrated that implantable neuromodulation can improve symptoms of NLUTD. We seek to describe our experience with sacral and pudendal neuromodulation in patie...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Continence Society
2024-12-01
|
| Series: | International Neurourology Journal |
| Subjects: | |
| Online Access: | http://einj.org/upload/pdf/inj-2448144-122.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849389360518004736 |
|---|---|
| author | Karis Buford Haley Eisner Annah Vollstedt Brett Friedman Jason Gilleran Bernadette M.M. Zwaans Kenneth M. Peters Priya Padmanabhan |
| author_facet | Karis Buford Haley Eisner Annah Vollstedt Brett Friedman Jason Gilleran Bernadette M.M. Zwaans Kenneth M. Peters Priya Padmanabhan |
| author_sort | Karis Buford |
| collection | DOAJ |
| description | Purpose Neurogenic lower urinary tract dysfunction (NLUTD) is highly prevalent among patients with neurologic disorders. Some studies have demonstrated that implantable neuromodulation can improve symptoms of NLUTD. We seek to describe our experience with sacral and pudendal neuromodulation in patients with NLUTD. Methods A retrospective chart review of patients with “neurogenic bladder” ICD-9/10 (International Classification of Diseases, Ninth Revision/10th Revision) code was performed at a single institution. This included patients from 2008 to 2020 who underwent stage 1 neuromodulation trial. Demographic and clinical information was collected, including neurologic diagnosis, the character of patients’ voiding symptoms, the presence or absence of fecal incontinence, the need for intermittent catheterization, and whether patients had sufficient (>50%) improvement in their symptoms to undergo stage 2 implantable pulse generator (IPG) placement. Results We identified 82 patients with neurologic diagnoses who underwent stage 1 neuromodulation. The most common diagnoses were diabetic cystopathy (17.07%), spinal surgery (17.07%), and spinal cord injury (12.20%). The most commonly reported symptoms were urinary urgency, and urge urinary incontinence. Overall, 59 patients (71.95%) advanced to stage 2 IPG placement including 72% of patients with sacral leads and 76% with pudendal leads. Conclusions Neuromodulation is feasible and effective in the treatment of NLUTD. Further investigation into its utilization is warranted. |
| format | Article |
| id | doaj-art-1ad42976c4dc429a98b844baff0eb0ae |
| institution | Kabale University |
| issn | 2093-4777 2093-6931 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Korean Continence Society |
| record_format | Article |
| series | International Neurourology Journal |
| spelling | doaj-art-1ad42976c4dc429a98b844baff0eb0ae2025-08-20T03:41:59ZengKorean Continence SocietyInternational Neurourology Journal2093-47772093-69312024-12-0128427828410.5213/inj.2448144.1221138Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective StudyKaris Buford0Haley Eisner1Annah Vollstedt2Brett Friedman3Jason Gilleran4Bernadette M.M. Zwaans5Kenneth M. Peters6Priya Padmanabhan7 Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA University of Iowa, Iowa City, IA, USA Oakland University William Beaumont School of Medicine, Rochester, MI, USA Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA Corewell Health William Beaumont University Hospital, Royal Oak, MI, USAPurpose Neurogenic lower urinary tract dysfunction (NLUTD) is highly prevalent among patients with neurologic disorders. Some studies have demonstrated that implantable neuromodulation can improve symptoms of NLUTD. We seek to describe our experience with sacral and pudendal neuromodulation in patients with NLUTD. Methods A retrospective chart review of patients with “neurogenic bladder” ICD-9/10 (International Classification of Diseases, Ninth Revision/10th Revision) code was performed at a single institution. This included patients from 2008 to 2020 who underwent stage 1 neuromodulation trial. Demographic and clinical information was collected, including neurologic diagnosis, the character of patients’ voiding symptoms, the presence or absence of fecal incontinence, the need for intermittent catheterization, and whether patients had sufficient (>50%) improvement in their symptoms to undergo stage 2 implantable pulse generator (IPG) placement. Results We identified 82 patients with neurologic diagnoses who underwent stage 1 neuromodulation. The most common diagnoses were diabetic cystopathy (17.07%), spinal surgery (17.07%), and spinal cord injury (12.20%). The most commonly reported symptoms were urinary urgency, and urge urinary incontinence. Overall, 59 patients (71.95%) advanced to stage 2 IPG placement including 72% of patients with sacral leads and 76% with pudendal leads. Conclusions Neuromodulation is feasible and effective in the treatment of NLUTD. Further investigation into its utilization is warranted.http://einj.org/upload/pdf/inj-2448144-122.pdfneuromodulationneurogenic lower urinary tract dysfunctionneurogenic bladderspina bifida |
| spellingShingle | Karis Buford Haley Eisner Annah Vollstedt Brett Friedman Jason Gilleran Bernadette M.M. Zwaans Kenneth M. Peters Priya Padmanabhan Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study International Neurourology Journal neuromodulation neurogenic lower urinary tract dysfunction neurogenic bladder spina bifida |
| title | Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study |
| title_full | Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study |
| title_fullStr | Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study |
| title_full_unstemmed | Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study |
| title_short | Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study |
| title_sort | implantable neuromodulation for neurogenic lower urinary tract dysfunction a single institution retrospective study |
| topic | neuromodulation neurogenic lower urinary tract dysfunction neurogenic bladder spina bifida |
| url | http://einj.org/upload/pdf/inj-2448144-122.pdf |
| work_keys_str_mv | AT karisbuford implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT haleyeisner implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT annahvollstedt implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT brettfriedman implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT jasongilleran implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT bernadettemmzwaans implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT kennethmpeters implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy AT priyapadmanabhan implantableneuromodulationforneurogeniclowerurinarytractdysfunctionasingleinstitutionretrospectivestudy |